5 Things To Know About Pharmacy Benefit Managers ArticleMar 13, 2024 5 Things To Know About Pharmacy Benefit Managers Pharmacy benefit managers are pharmaceutical middlemen that can inflate prescription drug costs for insurers and consumers. Mar 13, 2024 Nicole Rapfogel
The First Over-the-Counter Birth Control Pill Marks a Pivotal Moment in Birth Control Access ArticleMar 4, 2024 The First Over-the-Counter Birth Control Pill Marks a Pivotal Moment in Birth Control Access The first over-the-counter birth control pill will soon be available on shelves at retailers nationwide; we must ensure it is affordable and accessible to everyone. Mar 4, 2024 Kierra B. Jones
An Urgent Opportunity to Close the Medicaid Gap In the NewsFeb 23, 2024 An Urgent Opportunity to Close the Medicaid Gap Natasha Murphy writes in Governing about closing the Medicaid gap. Feb 23, 2024 Governing Natasha Murphy
Medicare Drug Price Negotiation Will Lower Prices by Thousands of Dollars per Month ArticleFeb 21, 2024 Medicare Drug Price Negotiation Will Lower Prices by Thousands of Dollars per Month A new analysis estimates prices for 30-day supplies of the first 10 Medicare Part D drugs undergoing price negotiations, with monthly reductions as high as $6,500 for some drugs. Feb 21, 2024 Nicole Rapfogel
Obamacare Has Been a Success, and It’s Just the Start In the NewsFeb 16, 2024 Obamacare Has Been a Success, and It’s Just the Start Nicole Rapfogel writes in The Ripon Forum about the benefits of the Affordable Care Act. Feb 16, 2024 The Ripon Forum Nicole Rapfogel
The Employer Public Option: A Tool for Improving Affordability via Alternative Health Coverage ReportJan 25, 2024 The Employer Public Option: A Tool for Improving Affordability via Alternative Health Coverage This report offers policy principles for employer public option reform to help reduce the cost of employer-sponsored insurance; lower health care prices; and increase workers’ access to affordable, comprehensive coverage. Jan 25, 2024 Natasha Murphy, Sam Hughes, Nicole Rapfogel
Federal Solutions To Address Rising Costs of Employer-Sponsored Insurance ReportJan 25, 2024 Federal Solutions To Address Rising Costs of Employer-Sponsored Insurance Federal policymakers should act to lower health insurance costs and improve affordability for both employers and workers. Jan 25, 2024 Sam Hughes, Nicole Rapfogel, Emily Gee
CAP Files Amicus Curiae Briefs Highlighting Importance of the Inflation Reduction Act in Lowering Drug Prices ArticleJan 23, 2024 CAP Files Amicus Curiae Briefs Highlighting Importance of the Inflation Reduction Act in Lowering Drug Prices These briefs emphasize the benefits of the Inflation Reduction Act’s Medicare prescription drug price negotiation program for affordability and health equity. Jan 23, 2024 Sophia Weaver, Marquisha Johns, Andrea Ducas, 3 More Jamie Crooks, Devon Ombres, Ben Olinsky
Testimony Before the House Education and the Workforce Subcommittee on Health, Employment, Labor and Pensions In the NewsJan 11, 2024 Testimony Before the House Education and the Workforce Subcommittee on Health, Employment, Labor and Pensions Andrea Ducas testified before the House Education and the Workforce Health, Employment, Labor and Pensions Subcommittee about reducing health care costs. Jan 11, 2024 House Education and the Workforce Committee Andrea Ducas
Long-Term Solutions to the Overincarceration of People With Mental Health Disabilities ReportJan 11, 2024 Long-Term Solutions to the Overincarceration of People With Mental Health Disabilities Policymakers must focus on long-term structural changes in order to reduce the negative interactions of people with mental health disabilities with police. Jan 11, 2024 Mia Ives-Rublee, Christina Stafford
CAP Files Amicus Curiae Brief Highlighting Importance of the Inflation Reduction Act in Lowering Drug Prices ArticleDec 22, 2023 CAP Files Amicus Curiae Brief Highlighting Importance of the Inflation Reduction Act in Lowering Drug Prices This brief, filed by the Center for American Progress and the NAACP in response to Boehringer Ingelheim Pharmaceuticals Inc. v. U.S. Department of Health and Human Services et al., emphasizes the benefits of the Inflation Reduction Act’s Medicare prescription drug price negotiation program for affordability and health equity. Dec 22, 2023 Sophia Weaver, Marquisha Johns, Andrea Ducas
The Supreme Court Will Review the Fate of Medication Abortion Care ArticleDec 13, 2023 The Supreme Court Will Review the Fate of Medication Abortion Care The same radical Supreme Court majority that eradicated the constitutional right to abortion will now review the approval of mifepristone. Dec 13, 2023 Sabrina Talukder